Muñoz-Galván, S.; Rivero, M.; Peinado-Serrano, J.; Martinez-PĂ©rez, J.; Fernández-Fernández, M.; JosĂ© Ortiz, M.; GarcĂa-Heredia, J.M.; Carnero, A.
PAI1 is a Marker of Bad Prognosis in Rectal Cancer but Predicts a Better Response to Treatment with PIM Inhibitor AZD1208. Cells 2020, 9, 1071.
https://doi.org/10.3390/cells9051071
AMA Style
Muñoz-Galván S, Rivero M, Peinado-Serrano J, Martinez-PĂ©rez J, Fernández-Fernández M, JosĂ© Ortiz M, GarcĂa-Heredia JM, Carnero A.
PAI1 is a Marker of Bad Prognosis in Rectal Cancer but Predicts a Better Response to Treatment with PIM Inhibitor AZD1208. Cells. 2020; 9(5):1071.
https://doi.org/10.3390/cells9051071
Chicago/Turabian Style
Muñoz-Galván, Sandra, Maria Rivero, Javier Peinado-Serrano, Julia Martinez-PĂ©rez, MC Fernández-Fernández, MarĂa JosĂ© Ortiz, JosĂ© M. GarcĂa-Heredia, and Amancio Carnero.
2020. "PAI1 is a Marker of Bad Prognosis in Rectal Cancer but Predicts a Better Response to Treatment with PIM Inhibitor AZD1208" Cells 9, no. 5: 1071.
https://doi.org/10.3390/cells9051071
APA Style
Muñoz-Galván, S., Rivero, M., Peinado-Serrano, J., Martinez-PĂ©rez, J., Fernández-Fernández, M., JosĂ© Ortiz, M., GarcĂa-Heredia, J. M., & Carnero, A.
(2020). PAI1 is a Marker of Bad Prognosis in Rectal Cancer but Predicts a Better Response to Treatment with PIM Inhibitor AZD1208. Cells, 9(5), 1071.
https://doi.org/10.3390/cells9051071